Report Overview

Rising prevalence of chronic diseases, increasing investments in healthcare infrastructure development, growing population, governments’ supportive initiatives, growing generic drug adoption, and improved access to healthcare services are expected to drive Middle East and Africa Pharmaceuticals Market during the forecast period between 2024 and 2030.

Middle East and Africa Pharmaceuticals Market– Industry Trends & Forecast Report, 2030

Middle East and Africa Pharmaceuticals Market size by value was estimated at USD 49.6 billion in 2023. During the forecast period between 2024 and 2030, Middle East and Africa Pharmaceuticals Market size is expected to expand at a CAGR of 6.80% reaching a value of USD 75.3 billion by 2030. Middle East and Africa Pharmaceuticals Market is driven by increasing disposable income, rapid urbanization, and a thriving hospitality industry. The growing demand for convenience, coupled with a rising preference for diverse cuisines, fuels market growth. Additionally, technological advancements like online booking platforms and economic diversification efforts under Vision 2030 contribute significantly.

Pharmaceuticals – Overview

Pharmaceuticals encompass the development, production, and marketing of drugs and medical therapies for various health conditions. They include prescription medications, over-the-counter drugs, and biologics. This industry is crucial for improving healthcare outcomes and involves rigorous research, clinical trials, and regulatory approvals. Leading pharmaceutical companies innovate to address unmet medical needs and improve the quality of life.

Middle East and Africa Pharmaceuticals Market

Growth Drivers

Increasing Prevalence of Chronic Diseases

Middle East and Africa region faces a rising burden of chronic diseases, including diabetes, cardiovascular disorders, cancer, and respiratory illnesses. This growing prevalence necessitates increased pharmaceutical interventions for effective management and treatment, driving significant market growth.

Challenges

Intense Competition

Middle East and Africa Pharmaceuticals Market faces intense competition due to the presence of numerous multinational and local companies. This fierce rivalry leads to price wars, reduced profit margins, and increased pressure on innovation and marketing efforts. Companies must continuously evolve and strategize to maintain market share and profitability.

Impact of Escalating Geopolitical Tensions on Middle East and Africa Pharmaceuticals Market

Middle East and Africa Pharmaceutical Market could be adversely affected by intensifying geopolitical tensions across the region. Economic, political, and trade tensions and sanctions could disrupt supply chains, leading to shortages of essential drugs and active pharmaceutical ingredients (APIs). Increased instabilities may also deter foreign investments and hinder the operations of local pharmaceutical companies. Additionally, conflicts could affect the distribution and availability of medications, exacerbating healthcare challenges in the region. Overall, geopolitical instabilities pose a substantial risk to the growth and stability of Pharmaceutical Market in Middle East & Africa.

Middle East and Africa Pharmaceuticals Market

Segmental Coverage

Middle East and Africa Pharmaceuticals Market – By Product Type

By product type, Middle East and Africa Pharmaceuticals Market is divided into Prescription Drugs, Over the Counter (OTC) Drugs, Generic Drugs, Branded Drugs, and Biopharmaceuticals segments. The prescription drugs segment is the largest product type in Middle East and Africa Pharmaceuticals Market, due to the increasing prevalence of chronic diseases, rising healthcare expenditure, and the growing availability of advanced therapeutic options. Prescription drugs dominate due to their essential role in managing critical health conditions and the strong regulatory framework ensuring their safe distribution. The segment also benefits from the expansion of healthcare infrastructure and the rising awareness about effective treatments across the region.

Middle East and Africa Pharmaceuticals Market – By Therapeutic Area

Middle East and Africa Pharmaceuticals Market by therapeutic area is divided into Cardiology, Oncology, Neurology, Infectious Diseases, Respiratory, and other segments. The infectious diseases segment is the largest therapeutic area in Middle East and Africa Pharmaceuticals Market. The segment’s dominance is driven by the region's higher prevalence of infectious diseases, such as malaria, tuberculosis, and HIV/AIDS, coupled with significant government and global health initiatives aimed at combating these conditions. The growing availability of vaccines, antiviral medications, and antibiotics, along with the region's focus on improving healthcare infrastructure, further supports the segment's growth and prominence in the pharmaceuticals market.

Middle East and Africa Pharmaceuticals Market – By Distribution Channel

On the basis of distribution channel, Middle East and Africa Pharmaceuticals Market is divided into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Wholesale/Distributors segments. The hospital pharmacies segment holds the largest share of Middle East and Africa Pharmaceuticals Market by distribution channel, due to the strong reliance on hospitals for access to prescription medications, specialized treatments, and critical care services in the region. The availability of a wide range of pharmaceuticals, especially for acute and chronic diseases, further solidifies their leading position. Additionally, public health systems and insurance coverage in many countries encourage the use of hospital pharmacies as a primary source of medication.

Middle East and Africa Pharmaceuticals Market – By End User

Based on end user, Middle East and Africa Pharmaceuticals Market is divided into Hospitals & Clinics, Retail Consumers, Academic & Research Institutes, and Contract Manufacturing Organizations (CMOs) segments. The hospitals & clinics segment is the largest end user in Middle East and Africa Pharmaceuticals Market. This dominance is driven by the region's expanding healthcare infrastructure, increasing prevalence of chronic and infectious diseases, and rising investments in healthcare services. Hospitals and clinics serve as primary points of care, particularly for prescription medications and advanced treatments. Additionally, government initiatives to improve healthcare access and the growth of private healthcare providers contribute significantly to the segment's leading position.

Middle East and Africa Pharmaceuticals Market – By Country

Geographically, Middle East and Africa Pharmaceuticals Market is divided into Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, and Rest of Middle East & Africa. Saudi Arabia is the leading country in Middle East and Africa Pharmaceuticals Market. The dominance is due to its robust healthcare infrastructure, high pharmaceutical spending, and government initiatives to localize drug manufacturing. The Kingdom’s Vision 2030 promotes significant investment in the healthcare sector, including pharmaceuticals. Additionally, the high prevalence of chronic diseases like diabetes and cardiovascular conditions drives demand for medications. The UAE and South Africa follow as prominent markets, supported by advanced healthcare systems and growing populations.

Competitive Landscape

Key players in the highly competitive Middle East and Africa Pharmaceuticals Market include Sanofi, Novartis, Pfizer, Merck, Roche, AstraZeneca, Johnson & Johnson, Bayer, Takeda Pharmaceutical Company Limited, and AbbVie. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Scope of the Report

Attributes	Details
Years Considered	Historical Data – 2019–2023
	Base Year – 2023
	Estimated Year – 2024
	Forecast Period – 2024–2030
Facts Covered	Revenue in USD Billion
Market Coverage	Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of Middle East & Africa
Product/Service Segmentation	Product Type, Therapeutic Area, Distribution Channel, End User
Key Players	Sanofi, Novartis, Pfizer, Merck, Roche, AstraZeneca, Johnson & Johnson, Bayer, Takeda Pharmaceutical Company Limited, AbbVie

 

 

By Product Type

• Prescription Drugs

• Over the Counter (OTC) Drugs

• Generic Drugs

• Branded Drugs

• Biopharmaceuticals

By Therapeutic Area

• Cardiology

• Oncology

• Neurology

• Infectious Diseases

• Respiratory

• Others

By Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

• Wholesale/Distributors

By End User

• Hospitals & Clinics

• Retail Consumers

• Academic & Research Institutes

• Contract Manufacturing Organizations (CMOs)

1. Research Framework
   1. Research Objective
   2. Product Overview
   3. Market Segmentation
2. Executive Summary
3. Middle East and Africa Pharmaceuticals Market Insights
   1. Industry Value Chain Analysis
      1. DROC Analysis
      2. Growth Drivers
         1. Rising Geriatric Population
         2. Prevalence of Chronic Diseases
         3. Advancements in Biotechnology and Medical Research
      3. Restraints
         1. Intense Competition
         2. Strict Regulatory Environment
      4. Opportunities
         1. Emerging Markets
         2. Government Initiatives and Healthcare Reforms
      5. Challenges
         1. High Research and Development Costs
         2. Price Controls and Reimbursement Challenges
   2. Technological Advancements/Recent Developments
   3. Regulatory Framework
   4. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
4. Middle East and Africa Pharmaceuticals Market: Marketing Strategies
5. Middle East and Africa Pharmaceuticals Market Overview
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Product Type
         1. Prescription Drugs
         2. Over the Counter (OTC) Drugs
         3. Generic Drugs
         4. Branded Drugs
         5. Biopharmaceuticals
      2. By Therapeutic Area
         1. Cardiology
         2. Oncology
         3. Neurology
         4. Infectious Diseases
         5. Respiratory
         6. Others
      3. By Distribution Channel
         1. Hospital Pharmacies
         2. Retail Pharmacies
         3. Online Pharmacies
         4. Wholesale/Distributors
      4. By End User
         1. Hospitals & Clinics
         2. Retail Consumers
         3. Academic & Research Institutes
         4. Contract Manufacturing Organizations (CMOs)
      5. By Country
         1. Saudi Arabia
         2. UAE
         3. Qatar
         4. Kuwait
         5. South Africa
         6. Nigeria
         7. Algeria
         8. Rest of Middle East and Africa
6. Saudi Arabia Pharmaceuticals Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Product Type
      2. By Therapeutic Area
      3. By Distribution Channel
      4. By End User
7. UAE Pharmaceuticals Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Product Type
      2. By Therapeutic Area
      3. By Distribution Channel
      4. By End User
8. Qatar Pharmaceuticals Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Product Type
      2. By Therapeutic Area
      3. By Distribution Channel
      4. By End User
9. Kuwait Pharmaceuticals Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Product Type
      2. By Therapeutic Area
      3. By Distribution Channel
      4. By End User
10. South Africa Pharmaceuticals Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Million)
    2. Market Share & Forecast
       1. By Product Type
       2. By Therapeutic Area
       3. By Distribution Channel
       4. By End User
11. Nigeria Pharmaceuticals Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Million)
    2. Market Share & Forecast
       1. By Product Type
       2. By Therapeutic Area
       3. By Distribution Channel
       4. By End User
12. Algeria Pharmaceuticals Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Million)
    2. Market Share & Forecast
       1. By Product Type
       2. By Therapeutic Area
       3. By Distribution Channel
       4. By End User
13. Rest of MEA Pharmaceuticals Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Million)
    2. Market Share & Forecast
       1. By Product Type
       2. By Therapeutic Area
       3. By Distribution Channel
       4. By End User
14. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Middle East and Africa Pharmaceuticals Company Market Share Analysis, 2023
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)
15. Impact of Escalating Geopolitical Tensions on Middle East and Africa Pharmaceuticals Market
16. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. Sanofi
    2. Novartis
    3. Pfizer
    4. Merck
    5. Roche
    6. AstraZeneca
    7. Johnson & Johnson
    8. Bayer
    9. Takeda Pharmaceutical Company Limited
    10. AbbVie
    11. Other Prominent Players
17. Key Strategic Recommendations
18. Research Methodology
    1.  Qualitative Research
       1.  Primary & Secondary Research
    2.  Quantitative Research
    3.  Market Breakdown & Data Triangulation
       1.  Secondary Research
       2.  Primary Research
    4.  Breakdown of Primary Research Respondents, By Region
    5.  Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

List of Figures

 

Figure 1       Middle East and Africa Pharmaceuticals Segmentation      

Figure 2       Middle East and Africa Pharmaceuticals Market Value Chain Analysis    

Figure 3       Company Market Share Analysis, 2023

Figure 4       Middle East and Africa Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Figure 5       Middle East and Africa Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030

Figure 6       Middle East and Africa Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 7       Middle East and Africa Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030

Figure 8       Middle East and Africa Pharmaceuticals Market Share, By End User, By Value, 2019–2030

Figure 9       Middle East and Africa Pharmaceuticals Market Share, By Country, By Value, 2019–2030

Figure 10     Saudi Arabia Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Figure 11     Saudi Arabia Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030

Figure 12     Saudi Arabia Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 13     Saudi Arabia Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030

Figure 14     Saudi Arabia Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030

Figure 15     UAE Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Figure 16     UAE Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030

Figure 17     UAE Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 18     UAE Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030

Figure 19     UAE Pharmaceuticals Market Share, By End User, By Value, 2019–2030

Figure 20     Qatar Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Figure 21     Qatar Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030

Figure 22     Qatar Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 23     Qatar Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030

Figure 24     Qatar Pharmaceuticals Market Share, By End User, By Value, 2019–2030

Figure 25     Kuwait Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Figure 26     Kuwait Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030

Figure 27     Kuwait Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 28     Kuwait Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030

Figure 29     Kuwait Pharmaceuticals Market Share, By End User, By Value, 2019–2030

Figure 30     South Africa Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Figure 31     South Africa Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030

Figure 32     South Africa Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 33     South Africa Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030

Figure 34     South Africa Pharmaceuticals Market Share, By End User, By Value, 2019–2030

Figure 35     Nigeria Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Figure 36     Nigeria Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030

Figure 37     Nigeria Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 38     Nigeria Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030

Figure 39     Nigeria Pharmaceuticals Market Share, By End User, By Value, 2019–2030

Figure 40     Algeria Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Figure 41     Algeria Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030

Figure 42     Algeria Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 43     Algeria Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030

Figure 44     Algeria Pharmaceuticals Market Share, By End User, By Value, 2019–2030

Figure 45     Rest of MEA Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Figure 46     Rest of MEA Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030

Figure 47     Rest of MEA Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 48     Rest of MEA Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030

Figure 49     Rest of MEA Pharmaceuticals Market Share, By End User, By Value, 2019–2030

 

List of Tables

 

Table 1        Middle East and Africa Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Table 2        Middle East and Africa Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030

Table 3        Middle East and Africa Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030

Table 4        Middle East and Africa Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030

Table 5        Middle East and Africa Pharmaceuticals Market Size, By End User, By Value, 2019–2030

Table 6        Middle East and Africa Pharmaceuticals Market Size, By Country, By Value, 2019–2030

Table 7        Saudi Arabia Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Table 8        Saudi Arabia Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030

Table 9        Saudi Arabia Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030

Table 10      Saudi Arabia Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030

Table 11      Saudi Arabia Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030

Table 12      UAE Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Table 13      UAE Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030

Table 14      UAE Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030

Table 15      UAE Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030

Table 16      UAE Pharmaceuticals Market Size, By End User, By Value, 2019–2030

Table 17      Qatar Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Table 18      Qatar Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030

Table 19      Qatar Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030

Table 20      Qatar Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030

Table 21      Qatar Pharmaceuticals Market Size, By End User, By Value, 2019–2030

Table 22      Kuwait Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Table 23      Kuwait Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030

Table 24      Kuwait Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030

Table 25      Kuwait Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030

Table 26      Kuwait Pharmaceuticals Market Size, By End User, By Value, 2019–2030

Table 27      South Africa Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Table 28      South Africa Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030

Table 29      South Africa Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030

Table 30      South Africa Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030

Table 31      South Africa Pharmaceuticals Market Size, By End User, By Value, 2019–2030

Table 32      Nigeria Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Table 33      Nigeria Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030

Table 34      Nigeria Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030

Table 35      Nigeria Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030

Table 36      Nigeria Pharmaceuticals Market Size, By End User, By Value, 2019–2030

Table 37      Algeria Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Table 38      Algeria Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030

Table 39      Algeria Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030

Table 40      Algeria Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030

Table 41      Algeria Pharmaceuticals Market Size, By End User, By Value, 2019–2030

Table 42      Rest of MEA Pharmaceuticals Market Size, By Value (USD Million), 2019–2030

Table 43      Rest of MEA Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030

Table 44      Rest of MEA Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030

Table 45      Rest of MEA Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030

Table 46      Rest of MEA Pharmaceuticals Market Size, By End User, By Value, 2019–2030

Table 47      Sanofi Company Overview

Table 48      Sanofi Financial Overview

Table 49      Novartis Company Overview

Table 50      Novartis Financial Overview

Table 51      Pfizer Company Overview

Table 52      Pfizer Financial Overview

Table 53      Merck Company Overview

Table 54      Merck Financial Overview

Table 55      Roche Company Overview

Table 56      Roche Financial Overview

Table 57      AstraZeneca Company Overview

Table 58      AstraZeneca Financial Overview

Table 59      Johnson & Johnson Company Overview

Table 60      Johnson & Johnson Financial Overview

Table 61      Bayer Company Overview

Table 62      Bayer Financial Overview

Table 63      Takeda Pharmaceutical Company Limited Company Overview

Table 64      Takeda Pharmaceutical Company Limited Financial Overview

Table 65      AbbVie Company Overview

Table 66      AbbVie Financial Overview